The US House of Representatives has voted in favour of providing legislative relief from the FDA’s deeming regulation, included in a massive spending bill to keep the government going
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.